Nota Bene: If this site is helpful for your work, please cite: Villoutreix et al. Drug Discovery Today 2013, 18:1081-9 or Singh, Chaput and Villoutreix, Briefings in Bioinformatics.
I'll do my best to remove dead content twice a year. For consulting see the About Me menu bar.
Last update Jan 9, 2023
I have been working at the interface between molecular medicine (mainly cancer, the complement system and blood coagulation), structural bioinformatics and chemoinformatics for over 20 years in different countries (USA, Finland, Sweden, France), in the private and academic sectors.
I am research director at the INSERM Institute (the French National Institute of Health and Medical Research is a public scientific and technological institute which operates under the joint authority of the French Ministry of Health and French Ministry of Research) and was head of the research unit U973 in Paris between 2009 and 2018. I am presently working in INSERM U1141, Robert-Debré Hospital, Paris - France.
I study novel targets and mechanisms such as those involving protein-protein interactions and transient protein-membrane interactions using different types of in silico approaches, in collaboration with experimental and clinical teams.
I am Editor in Chief of Frontiers in Drug Discovery, a new journal launched during Summer 2021.
Since 2003, I have been a consultant for biotechnology and pharmaceutical companies as well as for academic research groups and institutes...
In the post-genomic era, informatics technologies play a major role in medical research and pharmaceutical sciences and have become increasingly important in data management, lead-compound identification and in enhancing our understanding of the health and disease states (bioinformatics, chemoinformatics, data mining, dataviz, network...)...
The idea is to have very short scripts or one line codes, very simple ones to perform some simple tasks on chemistry and protein (or other) files